Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

Launched by NATIONAL CANCER INSTITUTE (NCI) · Nov 25, 2017

Keywords

ClinConnect Summary

This clinical trial is studying how advanced imaging techniques can help in understanding and treating prostate cancer, which is one of the most common cancers among men in the U.S. Researchers are collecting information about patients’ medical histories, test results, and imaging scans to see how these images can guide better diagnosis and treatment options. They hope that by profiling the cancer through imaging, they can improve the way prostate cancer is managed.

To participate in this trial, men aged 18 and older who have been diagnosed with or are suspected of having prostate cancer may be eligible, especially those with a strong family history of the disease or specific genetic mutations. Participants will allow researchers to use their medical information and imaging results, which will be analyzed to identify important patterns. There are no specific exclusions, making this trial open to many men who meet the criteria. If you or a loved one are interested, this could be a valuable opportunity to contribute to important research in prostate cancer care.

Gender

MALE

Eligibility criteria

• * INCLUSION CRITERIA:
• • Patients with an increased risk for prostate cancer (strong family history and/or germline mutation in DNA repair genes), or with a diagnosis of prostatic cancer or suspicious for prostatic cancer lesions.
• • Age greater than or equal to 18 years
• • Ability of subject to understand and the willingness to sign a written informed consent document.
• EXCLUSION CRITERIA:
• • -none